Professor of Neurology and Chairman of the Department of Neurology at the University of Duisburg-Essen, Germany
Past President of the German Neurological Society
Past President of the European Headache Federation
Immediate Past President of the International Headache Society
Professor Diener chairs the German Headache Consortium and the German Stroke Data Bank. His special research interests focus on headache, stroke and cerebellar physiology.
CoLucid was founded in 2005 by Pappas Ventures to advance innovative drug candidates with the potential to provide safe and effective treatments for CNS disorders. The company's investors include Pappas Ventures, Domain Associates, Care Capital, Pearl Street Venture Funds and Triathlon Medical Ventures.
Lasmiditan is a member of a novel chemical class called "ditans." Lasmiditan penetrates the central nervous system (CNS) and selectively targets 5-HT1F receptors expressed in the trigeminal nerve pathway.